World

Robert F Kennedy Jr urges supporters not to vote for him but Trump

Nov 05, 2024

Washington [US], November 5: Former US presidential candidate Robert F Kennedy Jr has used the eve of the election to call on people not to vote for him.
Kennedy, who is now supporting Republican Donald Trump against Democrat Kamala Harris, was unable to have his name removed from the ballot paper in several contested states once he pulled out.
"No matter what state you live in, do NOT vote for me," he said on X on Monday.
"Let's get President Trump back in the White House and me to Washington so we can Make America Healthy Again, end the forever wars, and protect our civil liberties."
The Republican former president had held out the prospect of appointing Kennedy, who is known as an anti-vaccination campaigner, to a role in his healthcare policy team if he wins.
At the end of October, the US Supreme Court rejected Kennedy's request to have his name removed from the ballot in the potentially decisive states of Wisconsin and Michigan. He is now worried that he could draw votes away from Trump.
The 70-year-old comes from the traditionally Democratic Kennedy family dynasty, but came out for Trump several weeks ago. (DPA)
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025